Literature DB >> 29399513

Thoracoscopic lobectomy after induction therapy-a paradigm shift?

Sameer A Hirji1, Asishana Osho2, Stafford S Balderson3, Thomas A D'Amico3.   

Abstract

Video-assisted thoracoscopic approaches (or VATS) have gained significant momentum in the management of locally advanced NSCLC in the current era. Accrual of experiences and concurrent improvements in instrumentation and video technology have further enhanced its role in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC). However, substantial controversy exists around the notion of mediastinal staging and restaging after induction therapy, the utility of induction chemotherapy versus chemoradiation for N2 disease, and subsequent role of video-assisted thoracoscopic surgery (VATS) lobectomy following induction therapy. This perspective will closely examine these issues in the context of existing guidelines and contemporary studies.

Entities:  

Keywords:  Thoracoscopy/video-assisted thoracoscopic surgery (VATS); induction therapy; lobectomy

Year:  2017        PMID： 29399513      PMCID： PMC5765266          DOI： 10.21037/jovs.2017.12.10

Source DB:  PubMed          Journal:  J Vis Surg        ISSN： 2221-2965


  24 in total

1.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

2.  Anatomic segmentectomy for stage I non-small-cell lung cancer: comparison of video-assisted thoracic surgery versus open approach.

Authors:  Matthew J Schuchert; Brian L Pettiford; Arjun Pennathur; Ghulam Abbas; Omar Awais; John Close; Arman Kilic; Robert Jack; James R Landreneau; Joshua P Landreneau; David O Wilson; James D Luketich; Rodney J Landreneau
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12       Impact factor: 5.209

3.  A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.

Authors:  Chi-Fu Jeffrey Yang; Arvind Kumar; Jacob A Klapper; Matthew G Hartwig; Betty C Tong; David H Harpole; Mark F Berry; Thomas A D'Amico
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

4.  Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.

Authors:  Chi-Fu Jeffrey Yang; Arvind Kumar; Brian C Gulack; Michael S Mulvihill; Matthew G Hartwig; Xiaofei Wang; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Cardiovasc Surg       Date:  2015-12-21       Impact factor: 5.209

5.  Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients.

Authors:  Chi-Fu Jeffrey Yang; Nicholas R Mayne; Hanghang Wang; Ryan R Meyerhoff; Sameer Hirji; Betty C Tong; Matthew Hartwig; David Harpole; Thomas A D'Amico; Mark Berry
Journal:  Ann Thorac Surg       Date:  2016-05-25       Impact factor: 4.330

Review 6.  Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer.

Authors:  Asad A Shah; Mark F Berry; Ching Tzao; Mihir Gandhi; Mathias Worni; Ricardo Pietrobon; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2012-06       Impact factor: 4.330

7.  A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).

Authors:  Nobuyuki Katakami; Hirohito Tada; Tetsuya Mitsudomi; Shinzoh Kudoh; Hiroshi Senba; Kaoru Matsui; Hideo Saka; Takayasu Kurata; Yasumasa Nishimura; Masahiro Fukuoka
Journal:  Cancer       Date:  2012-06-06       Impact factor: 6.860

8.  A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer.

Authors:  Gonzalo V Gonzalez-Stawinski; Anthony Lemaire; Faisal Merchant; Elizabeth O'Halloran; R Edward Coleman; David H Harpole; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

9.  Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.

Authors:  Chi-Fu Jeffrey Yang; Brian C Gulack; Lin Gu; Paul J Speicher; Xiaofei Wang; David H Harpole; Mark W Onaitis; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-02       Impact factor: 5.209

10.  Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Gregory J Riely; Wallace Akerley; Hossein Borghaei; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Ramaswamy Govindan; Frederic W Grannis; Stefan C Grant; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Feng-Ming Spring Kong; Mark G Kris; Lee M Krug; Rudy P Lackner; Inga T Lennes; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Mary C Pinder-Schenck; Katherine M Pisters; Karen Reckamp; Eric Rohren; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Douglas E Wood; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908
View more
  1 in total

Review 1.  [Results of N1 and N2 surgery in non-small cell lung cancer].

Authors:  J Pfannschmidt; J Kollmeier
Journal:  Chirurg       Date:  2019-12       Impact factor: 0.955
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.